These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 15297822)

  • 1. The use of the Angioseal device for femoral artery closure.
    Abando A; Hood D; Weaver F; Katz S
    J Vasc Surg; 2004 Aug; 40(2):287-90. PubMed ID: 15297822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of the StarClose device for obtaining femoral artery hemostasis.
    Rodriguez A; Katz SG
    Vasc Endovascular Surg; 2011 Oct; 45(7):627-30. PubMed ID: 21646232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FemoSeal
    Gabrielli R; Rosati MS; Millarelli M; Dante A; Maiorano M; Musilli A; Chiappa R; Ventura M
    Ann Vasc Surg; 2018 Aug; 51():18-24. PubMed ID: 29678650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of the angioseal vascular closure device post antegrade puncture.
    Looby S; Keeling AN; McErlean A; Given MF; Geoghegan T; Lee MJ
    Cardiovasc Intervent Radiol; 2008; 31(3):558-62. PubMed ID: 18253787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angioseal VIP® vs. StarClose SE® closure devices: a comparative analysis in non-cardiological procedures.
    Lucatelli P; Fanelli F; Cannavale A; Corona M; Cirelli C; D'Adamo A; Salvatori FM; Catalano C
    J Cardiovasc Surg (Torino); 2017 Feb; 58(1):80-86. PubMed ID: 24309473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and safety of closure of brachial access using the AngioSeal closure device: experience with 161 interventions in diabetic patients with critical limb ischemia.
    Lupattelli T; Clerissi J; Clerici G; Minnella DP; Casini A; Losa S; Faglia E
    J Vasc Surg; 2008 Apr; 47(4):782-8. PubMed ID: 18295438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and effectiveness of repeat arterial closure using the AngioSeal device in patients with hepatic malignancy.
    Hieb RA; Neisen MJ; Hohenwalter EJ; Molnar JA; Rilling WS
    J Vasc Interv Radiol; 2008 Dec; 19(12):1704-8. PubMed ID: 18951046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of closure devices.
    Katz SG; Abando A
    Surg Clin North Am; 2004 Oct; 84(5):1267-80, vi. PubMed ID: 15364554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and complications of Angioseal in antegrade puncture.
    Mukhopadhyay K; Puckett MA; Roobottom CA
    Eur J Radiol; 2005 Dec; 56(3):409-12. PubMed ID: 16298678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety and efficacy of angioseal in therapeutic endovascular interventions.
    Aksoy M; Becquemin JP; Desgranges P; Allaire E; Kobeiter H
    Eur J Vasc Endovasc Surg; 2006 Jul; 32(1):90-3. PubMed ID: 16478672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Efficacy of Arterial Closure Devices in an Office-Based Angiosuite.
    Jones LE; Yang KH; Feldtman RW; Uceda PV; Ferrara CA; Caruso JM; Richmond JL; Ahn SS
    Ann Vasc Surg; 2018 Aug; 51():10-17. PubMed ID: 29655814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity: an independent risk factor for insufficient hemostasis using the AngioSeal vascular closure device after antegrade puncture.
    Minko P; Katoh M; Gräber S; Buecker A
    Cardiovasc Intervent Radiol; 2012 Aug; 35(4):775-8. PubMed ID: 21792734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular complications after percutaneous coronary intervention following hemostasis with the Mynx vascular closure device versus the AngioSeal vascular closure device.
    Azmoon S; Pucillo AL; Aronow WS; Ebrahimi R; Vozzolo J; Rajdev A; Kalapatapu K; Ro JH; Hjemdahl-Monsen C
    J Invasive Cardiol; 2010 Apr; 22(4):175-8. PubMed ID: 20351388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial experience with the Cardiva Boomerang vascular closure device in diagnostic catheterization.
    Doyle BJ; Godfrey MJ; Lennon RJ; Ryan JL; Bresnahan JF; Rihal CS; Ting HH
    Catheter Cardiovasc Interv; 2007 Feb; 69(2):203-8. PubMed ID: 17195965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemostatic Wound Dressing for Postinterventional Hemostasis in Large Femoral Artery Access Sites: An Initial Efficacy and Safety Study.
    Sauer A; Dierks A; Wolfschmidt F; Hassold N; Bley TA; Kickuth R
    J Endovasc Ther; 2016 Oct; 23(5):744-50. PubMed ID: 27385152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: Looby et al.: "Efficacy and safety of the Angioseal vascular closure device post antegrade puncture".
    Thurley PD; O'Neill R; Habib S; Whitaker SC
    Cardiovasc Intervent Radiol; 2008; 31(6):1255-6. PubMed ID: 18756370
    [No Abstract]   [Full Text] [Related]  

  • 17. AbsorbaSeal™ Vascular Closure Device: A Novel Device for Hemostasis Following Interventional Peripheral Vascular Procedures.
    Benham E; Deloose K; Callaert J; Bosiers M; Cox T; Lincourt A; Heniford BT
    Surg Technol Int; 2017 Oct; 31():93-99. PubMed ID: 29020709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated ambulation after vascular access closure device.
    Brancheau D; Sarsam S; Assaad M; Zughaib M
    Ther Adv Cardiovasc Dis; 2018 May; 12(5):141-144. PubMed ID: 29421959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of the StarClose arterial closure device in patients with peripheral arterial disease.
    Gray BH; Miller R; Langan EM; Joels CS; Yasin Y; Kalbaugh CA
    Ann Vasc Surg; 2009; 23(3):341-4. PubMed ID: 18809287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic Review of Randomized Controlled Trials Comparing Manual Compression to Vascular Closure Devices for Diagnostic and Therapeutic Arterial Procedures.
    Cox T; Blair L; Huntington C; Lincourt A; Sing R; Heniford BT
    Surg Technol Int; 2015 Nov; 27():32-44. PubMed ID: 26680377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.